Comparison of the effects of Topiramate and Gabapentin in Opioid withdrawal syndrome

Phase 3

• Conditions: Opioid Withdrawal syndrome.; Opioid dependence with withdrawal; F11.23

• Registration Number: IRCT20210427051102N1
• Lead Sponsor: Fasa University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Detection of opioid dependence according to DSM-V criteria

Exclusion Criteria

Major medical diseases including cardiovascular, pulmonary, renal and gastrointestinal disorders
Pregnancy and Lactation period

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The score of Opioid Withdrawal Syndrome in the Questionnaire. Timepoint: Before intervention and 3, 5, 7, 9 and 11 days after starting gabapentin or topiramate. Method of measurement: Subjective Opiate Withdrawal Scale.